TradeStation President John Bartleman: Cryptocurrency "Here to Stay"
Cryptocurrency has investors in a frenzy, with some swearing by it, and others warning of instability and bubbles. In the pro-crypto camp is John Bartleman, president at digital brokerage firm TradeStation, who believes that digital currency is the future.
“I think this is here to stay, I think we are in the early days, somewhat like the internet in the early 80s, early 90s” he said.
Bitcoin is the top cryptocurrency now, shooting up the charts and, in a matter of weeks, jumping from $8,000 to over $11,000. Some analysts say there’s no reason for the hike, and swear the bubble is about to burst.
JPMorgan's Jamie Dimon, one of the most notable naysayers, says the Bitcoin currency is a fraudulent system, too often used for illicit purposes. Similarly, the CBOE recently announced it will launch Bitcoin futures trading as of December 10th, offering free trading through the month of December. The exchange says the move will provide “transparency, efficient price discovery, deep liquidity, and centralized clearing,” to investors.
Bartleman does agree that there is a lot of fraud as of now, and that the digital currency can see a correction, but he contends that “there’s real value in [crypto].”
“In the next five years, I think we will find ourselves in a place where retail customers will be interactive, trading in different type of crypto companies,” Bartleman said.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.